Drugs / [11C]APP311
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 0 | NCT05472818 Comparator | Apr 2022 → May 2027 expected | cannabis dependence | Yale University | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | [11C]APP311 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05472818 ↗ |
| Known as | UCB-J | “For each \[11C\]APP311 (UCB-J) PET scan, up to 20 mCi of \[11C\]APP311 (UCB-J) will be administered by infusion pump.” NCT05472818 ↗ |